| | Characteristics | Cardiac event (−) | Cardiac event (+) | value |
| | Age (years) | 63 (55, 71) | 63 (57, 72) | 0.889 | | Male (, %) | 65 (63.7) | 67 (48.6) | 0.026 | | Smoking (, %) | 32 (31.4) | 30 (21.8%) | 0.184 | | BMI (kg/m2) | 23.5 (21.7, 25.2) | 23.3 (21.4, 24.8) | 0.278 | | HR (bpm) | 71 (63, 75) | 68 (63, 76) | 0.375 | | SBP (mmHg) | 114 (104, 125) | 115 (107, 126) | 0.251 | | DBP (mmHg) | 73 (65, 78) | 75 (67, 80) | 0.160 | | TC (mmol/l) | 4.1 (3.6, 4.6) | 4.1 (3.5, 4.6) | 0.599 | | TG (mmol/l) | 1.0 (0.8, 1.3) | 1.0 (0.5, 1.3) | 0.914 | | HDL-C (mmol/l) | 1.0 (0.7, 1.3) | 0.9 (0.8, 1.1) | 0.898 | | LDL-C (mmol/l) | 2.0 (1.5, 2.5) | 1.9 (1.4, 2.6) | 0.582 | | Glu (mmol/l) | 5.7 (4.9, 6.6) | 5.4 (4.9, 6.4) | 0.252 | | Albumin (g/l) | 39 (35, 42) | 38 (35, 41) | 0.285 | | CREA (μmol/l) | 92 (73, 120) | 92 (73, 124) | 0.965 | | CRP (mg/l) | 9.6 (4.7, 18.4) | 6.0 (2.6, 14.8) | 0.005 | | NT-pro BNP (pg/ml) | 3763 (2452, 5224) | 3573 (2349, 5253) | 0.897 | | LVEF (%) | 39 (35, 42) | 39 (35, 42) | 0.299 | | LVEDD (mm) | 54 (50, 59) | 56 (52, 62) | 0.047 | | NYHA functional class, II/III/IV | 28/34/40 | 42/42/54 | 0.783/0.791/0.994 | | DCM (, %) | 32 (31.4%) | 36 (26.1%) | 0.545 | | IHD (, %) | 36 (35.3%) | 38 (27.5%) | 0.426 | | HHD (, %) | 22 (21.6%) | 40 (29.0%) | 0.404 | | Others (, %) | 20 (19.6%) | 16 (11.6%) | 0.302 | | Medications, (, %) | | | | | ACEI/ARB | 76 (74.5%) | 86 (62.3%) | 0.052 | | β-Blockers | 36 (35.3%) | 56 (40.6%) | 0.423 | | Diuretics | 61 (59.8%) | 86 (62.3%) | 0.789 | | Digitalis | 72 (70.6%) | 94 (68.1%) | 0.887 | | Spironolactone | 46 (45.1%) | 72 (52.2%) | 0.241 | | Aspirin | 44 (43.1%) | 54 (39.1%) | 0.598 | | Statin | 29 (28.4%) | 32 (23.2%) | 0.454 |
|
|
